Eve review
Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $273/mo — $74 above our category median of $199.
- Semaglutide
- $273/mo
- Tirzepatide
- $406/mo
- Coverage
- Coverage not published
- Brand-name
- Yes
- Oral option
- Yes
- Verification
- LegitScript-certified
Best for: People who want women's-health GLP-1 with compounded or brand-name access.
MatchScript's take: Our #419 pick of 537 — one of the few with a non-injection route.
The factor breakdown
Eve on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $273/mo puts Budget Fit at a below-par 43 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
Eve adds an oral/sublingual route and brand-name access on top of injectables, for a strong 90 on Formulary Match.
Support lands at a below-par 71 — lighter, meds-first support.
Flexibility scores a below-par 41 — fewer levers to flex your plan.
LegitScript certification helps, but thin pricing and sourcing detail keeps Transparency at a below-par 28.
Pricing in context
How Eve's monthly price sits against the category median and the cheapest provider we track.
What we like
- Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
- Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Oral sublingual semaglutide offered alongside injectable
The caveats
- Full states-served list not disclosed publicly
- 503A pharmacy partner not named, and 503A vs 503B status not specified
- Named medical director / clinical leadership not disclosed
- Corporate legal entity not disclosed
- Governing law / arbitration venue not stated
Who it's for — and who should skip it
Eve is for people who want women's-health GLP-1 with compounded or brand-name access.
Skip it if that doesn't sound like you. A closer fit may be HumeCare+ (Match Score 53) — or take the quiz to see where Eve lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Eve against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Evethis provider | CoreAge Rxour #1 | Aquivia Healthclosest scorer |
|---|---|---|---|
| Sema price | $273/mo | $99/mo at every dose | $271/mo |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + oral + brand | Injectable | Injectable + brand |
| Match Score | 55 · C | 91 · A− | 55 · C |
Eve, answered
Is Eve legit?
Yes — Eve is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved; confirm your prescriber is US-licensed at intake.
How much does Eve cost?
Eve lists compounded semaglutide from $273/mo and tirzepatide from $406/mo — above our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does Eve ship to my state?
Eve doesn't publish a full state list, so confirm your state is covered during intake before you pay.
Eve vs HumeCare+ — which should I pick?
They score within a few points of each other: Eve at 55/100 and HumeCare+ at 53/100, so neither wins on the headline number. Eve is the better fit for people who want women's-health GLP-1 with compounded or brand-name access. HumeCare+ suits people who want GLP-1 weight loss with real-time body-composition tracking to protect muscle. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from Eve's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Eve's site. Not medical advice; see our disclosure.
Semaglutide here is $273/mo — $74 above our category median of $199. Tirzepatide is $406/mo. Its strongest suit is the range of medication it offers. Best suited to people who want women's-health GLP-1 with compounded or brand-name access. If that is not you, HumeCare+ is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Eve here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Rivas Medical Weight Loss#420 | 55 | $500/mo | $717/mo | 3 states | Alternatives | Visit |
| Balanced Hormone Health#421 | 55 | Not disclosed | $181/mo | Coverage not published | Alternatives | Visit |
| Good Life Meds#422 | 55 | $202/mo | $301/mo | Coverage not published | Alternatives | Visit |
| Klarity Health#423 | 55 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Medi-Weightloss#424 | 55 | $199/mo (promotional rate, brand-name) | Not disclosed | Coverage not published | Alternatives | Visit |
| Meto#425 | 55 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| RedBox Rx#426 | 55 | $269/mo (all doses, 6-month plan, compounded) | $429/mo | Coverage not published | Alternatives | Visit |
| Tonik Wellness#427 | 55 | $225/mo (compounded) | $349/mo (compounded) | Coverage not published | Alternatives | Visit |
| VivioMD#428 FDA issued VivioMD Group LLC dba VivioMD a warning letter in June 2026. See FDA's warning-letter database. | 55 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Walgreens Weight Management#429 | 55 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| LifespanningRx#430 | 55 | $213/mo | $213/mo | All 50 states | Alternatives | Visit |
| tru Weight Loss#431 | 55 | $299/mo (all doses, 3-month plan, compounded) | $399/mo (all doses, 3-month plan, compounded) | Coverage not published | Alternatives | Visit |
| Ascend Vitality#432 | 55 | $199/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| Concierge MD LA#433 | 55 | $202/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Nouri#434 | 55 | $175/mo | $225/mo | All 50 states | Alternatives | Visit |
| TeleZen MD#435 | 55 | $198/mo (compounded) | $272/mo | Coverage not published | Alternatives | Visit |
| UR Meds#436 | 54 | $271/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| ClickSlim#437 | 54 | Not disclosed | $399/mo | Coverage not published | Alternatives | Visit |
| Vea Health#438 | 54 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| RxSaludable#439 | 54 | $179/mo (compounded) | $399/mo | Coverage not published | Alternatives | Visit |
| Vita Bella#440 | 54 | $241/mo | $292/mo | 46 states | Alternatives | Visit |
| TeleDocs360#441 | 54 | $325/mo | $434/mo | Coverage not published | Alternatives | Visit |
| Zealthy#442 FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025. See FDA's warning-letter database. | 54 | $248/mo | $359/mo | 34 states | Alternatives | Visit |
| Aspire Health#443 | 54 | $105/mo | $211/mo | Coverage not published | Alternatives | Visit |
Eve is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs, best brand-name GLP-1 providers and best oral GLP-1 providers boards, scored on the same six factors as every other provider there.